Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric Cancer
Status:
Recruiting
Trial end date:
2025-05-31
Target enrollment:
Participant gender:
Summary
The efficacy of HIPEC in prevention of local recurrence, distant metastasis or peritoneal
metastasis in locally advanced gastric cancer is not definite. The hypothesis of the trial is
that radical gastrectomy combined with HIPEC is superior to only radical gastrectomy in terms
of overall survival.